United States · Series B startup
4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$51Mraised across 4 rounds since 2007, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by hemaquest.comSEC filing: $6.5M sold, first sale Mar 2012
No investor was named in the report.
Reported by sec.govSEC filing: $6.5M sold, first sale Mar 2012
Reported by fiercebiotech.comSEC filing: $6.0M sold, first sale Jan 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Forward Ventures
Aberdare Ventures
Lilly Ventures
Lilly VenturesMissing a round, or an investor who was in one? Tell us.
HemaQuest Pharmaceuticals's investors include De Novo Ventures, Forward Ventures, Aberdare Ventures, Lilly Ventures and Latterell Venture Partners, and 1 more on record.
HemaQuest Pharmaceuticals has raised $51M across 4 rounds since 2007.
HemaQuest Pharmaceuticals's most recent round was a Series B of $13M in Mar 2012.
HemaQuest Pharmaceuticals's largest round on record is $20M (Series A), in Nov 2007.
HemaQuest Pharmaceuticals's first round on record, in Nov 2007, was backed by De Novo Ventures, Forward Ventures and Lilly Ventures.
HemaQuest Pharmaceuticals's latest named round is a Series B, in Mar 2012.
HemaQuest Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
